3.22.4 html 202 408 1 false 87 0 false 11 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.cumberlandpharma.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.cumberlandpharma.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets Sheet http://www.cumberlandpharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.cumberlandpharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Operations Sheet http://www.cumberlandpharma.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.cumberlandpharma.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Statement - Consolidated Statements of Equity Sheet http://www.cumberlandpharma.com/role/ConsolidatedStatementsofEquity Consolidated Statements of Equity Statements 7 false false R8.htm 0000008 - Statement - Valuation and Qualifying Accounts Sheet http://www.cumberlandpharma.com/role/ValuationandQualifyingAccounts Valuation and Qualifying Accounts Statements 8 false false R9.htm 0000009 - Disclosure - Organization Sheet http://www.cumberlandpharma.com/role/Organization Organization Notes 9 false false R10.htm 0000010 - Disclosure - Significant Accounting Policies Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 0000011 - Disclosure - RediTrex??, Vibativ?? and Sancuso?? Sheet http://www.cumberlandpharma.com/role/RediTrexVibativandSancuso RediTrex??, Vibativ?? and Sancuso?? Notes 11 false false R12.htm 0000012 - Disclosure - Revenues Sheet http://www.cumberlandpharma.com/role/Revenues Revenues Notes 12 false false R13.htm 0000013 - Disclosure - Inventories Sheet http://www.cumberlandpharma.com/role/Inventories Inventories Notes 13 false false R14.htm 0000014 - Disclosure - Property and Equipment Sheet http://www.cumberlandpharma.com/role/PropertyandEquipment Property and Equipment Notes 14 false false R15.htm 0000015 - Disclosure - Intangible Assets and Goodwill Sheet http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwill Intangible Assets and Goodwill Notes 15 false false R16.htm 0000016 - Disclosure - Other Current and Other Long-term Liabilities Sheet http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilities Other Current and Other Long-term Liabilities Notes 16 false false R17.htm 0000017 - Disclosure - Debt Sheet http://www.cumberlandpharma.com/role/Debt Debt Notes 17 false false R18.htm 0000018 - Disclosure - Shareholders' Equity Sheet http://www.cumberlandpharma.com/role/ShareholdersEquity Shareholders' Equity Notes 18 false false R19.htm 0000019 - Disclosure - Earnings (Loss) Per Share Sheet http://www.cumberlandpharma.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 19 false false R20.htm 0000020 - Disclosure - Income Taxes Sheet http://www.cumberlandpharma.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 0000021 - Disclosure - Stock-Based Compensation Plans Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlans Stock-Based Compensation Plans Notes 21 false false R22.htm 0000022 - Disclosure - Employee Benefit Plans Sheet http://www.cumberlandpharma.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 22 false false R23.htm 0000023 - Disclosure - Leases Sheet http://www.cumberlandpharma.com/role/Leases Leases Notes 23 false false R24.htm 0000024 - Disclosure - Market Concentrations Sheet http://www.cumberlandpharma.com/role/MarketConcentrations Market Concentrations Notes 24 false false R25.htm 0000025 - Disclosure - Manufacturing and Supply Agreements Sheet http://www.cumberlandpharma.com/role/ManufacturingandSupplyAgreements Manufacturing and Supply Agreements Notes 25 false false R26.htm 0000026 - Disclosure - Employment Agreements Sheet http://www.cumberlandpharma.com/role/EmploymentAgreements Employment Agreements Notes 26 false false R27.htm 0000027 - Disclosure - Discontinued Operations Sheet http://www.cumberlandpharma.com/role/DiscontinuedOperations Discontinued Operations Notes 27 false false R28.htm 0000028 - Disclosure - Commitments and Contingencies Sheet http://www.cumberlandpharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 28 false false R29.htm 0000029 - Disclosure - Quarterly Financial Information (Unaudited) Sheet http://www.cumberlandpharma.com/role/QuarterlyFinancialInformationUnaudited Quarterly Financial Information (Unaudited) Notes 29 false false R30.htm 0000030 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.cumberlandpharma.com/role/SignificantAccountingPolicies 30 false false R31.htm 0000031 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.cumberlandpharma.com/role/SignificantAccountingPolicies 31 false false R32.htm 0000032 - Disclosure - RediTrex??, Vibativ?? and Sancuso?? (Tables) Sheet http://www.cumberlandpharma.com/role/RediTrexVibativandSancusoTables RediTrex??, Vibativ?? and Sancuso?? (Tables) Tables http://www.cumberlandpharma.com/role/RediTrexVibativandSancuso 32 false false R33.htm 0000033 - Disclosure - Revenues (Tables) Sheet http://www.cumberlandpharma.com/role/RevenuesTables Revenues (Tables) Tables http://www.cumberlandpharma.com/role/Revenues 33 false false R34.htm 0000034 - Disclosure - Inventories (Tables) Sheet http://www.cumberlandpharma.com/role/InventoriesTables Inventories (Tables) Tables http://www.cumberlandpharma.com/role/Inventories 34 false false R35.htm 0000035 - Disclosure - Property and Equipment (Tables) Sheet http://www.cumberlandpharma.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.cumberlandpharma.com/role/PropertyandEquipment 35 false false R36.htm 0000036 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwill 36 false false R37.htm 0000037 - Disclosure - Other Current and Other Long-term Liabilities (Tables) Sheet http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilitiesTables Other Current and Other Long-term Liabilities (Tables) Tables http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilities 37 false false R38.htm 0000038 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.cumberlandpharma.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.cumberlandpharma.com/role/EarningsLossPerShare 38 false false R39.htm 0000039 - Disclosure - Income Taxes (Tables) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.cumberlandpharma.com/role/IncomeTaxes 39 false false R40.htm 0000040 - Disclosure - Stock-Based Compensation Plans (Tables) Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlansTables Stock-Based Compensation Plans (Tables) Tables http://www.cumberlandpharma.com/role/StockBasedCompensationPlans 40 false false R41.htm 0000041 - Disclosure - Leases (Tables) Sheet http://www.cumberlandpharma.com/role/LeasesTables Leases (Tables) Tables http://www.cumberlandpharma.com/role/Leases 41 false false R42.htm 0000042 - Disclosure - Market Concentrations (Tables) Sheet http://www.cumberlandpharma.com/role/MarketConcentrationsTables Market Concentrations (Tables) Tables http://www.cumberlandpharma.com/role/MarketConcentrations 42 false false R43.htm 0000043 - Disclosure - Quarterly Financial Information (Unaudited) (Tables) Sheet http://www.cumberlandpharma.com/role/QuarterlyFinancialInformationUnauditedTables Quarterly Financial Information (Unaudited) (Tables) Tables http://www.cumberlandpharma.com/role/QuarterlyFinancialInformationUnaudited 43 false false R44.htm 0000044 - Disclosure - Organization (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/OrganizationNarrativeDetails Organization (Narrative) (Details) Details http://www.cumberlandpharma.com/role/Organization 44 false false R45.htm 0000045 - Disclosure - Significant Accounting Policies (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesNarrativeDetails Significant Accounting Policies (Narrative) (Details) Details http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesTables 45 false false R46.htm 0000046 - Disclosure - Significant Accounting Policies (Schedule of Intangible Assets, Useful Lives) (Details) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleofIntangibleAssetsUsefulLivesDetails Significant Accounting Policies (Schedule of Intangible Assets, Useful Lives) (Details) Details http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesTables 46 false false R47.htm 0000047 - Disclosure - Significant Accounting Policies (Schedule of Distribution Costs) (Details) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleofDistributionCostsDetails Significant Accounting Policies (Schedule of Distribution Costs) (Details) Details http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesTables 47 false false R48.htm 0000048 - Disclosure - Significant Accounting Policies (Schedule of Advertising Costs) (Details) Sheet http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesScheduleofAdvertisingCostsDetails Significant Accounting Policies (Schedule of Advertising Costs) (Details) Details http://www.cumberlandpharma.com/role/SignificantAccountingPoliciesTables 48 false false R49.htm 0000049 - Disclosure - RediTrex??, Vibativ?? and Sancuso?? - Narrative (Details) Sheet http://www.cumberlandpharma.com/role/RediTrexVibativandSancusoNarrativeDetails RediTrex??, Vibativ?? and Sancuso?? - Narrative (Details) Details 49 false false R50.htm 0000050 - Disclosure - RediTrex??, Vibativ?? and Sancuso?? - Schedule of Contingent Consideration and Preliminary Allocation (Details) Sheet http://www.cumberlandpharma.com/role/RediTrexVibativandSancusoScheduleofContingentConsiderationandPreliminaryAllocationDetails RediTrex??, Vibativ?? and Sancuso?? - Schedule of Contingent Consideration and Preliminary Allocation (Details) Details 50 false false R51.htm 0000051 - Disclosure - RediTrex??, Vibativ?? and Sancuso?? - Pro Forma Results (Details) Sheet http://www.cumberlandpharma.com/role/RediTrexVibativandSancusoProFormaResultsDetails RediTrex??, Vibativ?? and Sancuso?? - Pro Forma Results (Details) Details 51 false false R52.htm 0000052 - Disclosure - Revenues (Schedule of Net Product Revenues by Product) (Details) Sheet http://www.cumberlandpharma.com/role/RevenuesScheduleofNetProductRevenuesbyProductDetails Revenues (Schedule of Net Product Revenues by Product) (Details) Details http://www.cumberlandpharma.com/role/RevenuesTables 52 false false R53.htm 0000053 - Disclosure - Revenues (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/RevenuesNarrativeDetails Revenues (Narrative) (Details) Details http://www.cumberlandpharma.com/role/RevenuesTables 53 false false R54.htm 0000054 - Disclosure - Inventories (Schedule of Inventories) (Details) Sheet http://www.cumberlandpharma.com/role/InventoriesScheduleofInventoriesDetails Inventories (Schedule of Inventories) (Details) Details http://www.cumberlandpharma.com/role/InventoriesTables 54 false false R55.htm 0000055 - Disclosure - Inventories (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/InventoriesNarrativeDetails Inventories (Narrative) (Details) Details http://www.cumberlandpharma.com/role/InventoriesTables 55 false false R56.htm 0000056 - Disclosure - Property and Equipment (Schedule of Property and Equipment) (Details) Sheet http://www.cumberlandpharma.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails Property and Equipment (Schedule of Property and Equipment) (Details) Details http://www.cumberlandpharma.com/role/PropertyandEquipmentTables 56 false false R57.htm 0000057 - Disclosure - Property and Equipment (Depreciation Expense) (Details) Sheet http://www.cumberlandpharma.com/role/PropertyandEquipmentDepreciationExpenseDetails Property and Equipment (Depreciation Expense) (Details) Details http://www.cumberlandpharma.com/role/PropertyandEquipmentTables 57 false false R58.htm 0000058 - Disclosure - Intangible Assets and Goodwill (Schedule of Intangible Assets) (Details) Sheet http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails Intangible Assets and Goodwill (Schedule of Intangible Assets) (Details) Details http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillTables 58 false false R59.htm 0000059 - Disclosure - Intangible Assets and Goodwill (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillNarrativeDetails Intangible Assets and Goodwill (Narrative) (Details) Details http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillTables 59 false false R60.htm 0000060 - Disclosure - Intangible Assets and Goodwill - Future Amortization Expense (Details) Sheet http://www.cumberlandpharma.com/role/IntangibleAssetsandGoodwillFutureAmortizationExpenseDetails Intangible Assets and Goodwill - Future Amortization Expense (Details) Details 60 false false R61.htm 0000061 - Disclosure - Other Current and Other Long-term Liabilities (Schedule of Other Current Liabilities) (Details) Sheet http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilitiesScheduleofOtherCurrentLiabilitiesDetails Other Current and Other Long-term Liabilities (Schedule of Other Current Liabilities) (Details) Details http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilitiesTables 61 false false R62.htm 0000062 - Disclosure - Other Current and Other Long-term Liabilities (Schedule of Noncurrent Liabilities) (Details) Sheet http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilitiesScheduleofNoncurrentLiabilitiesDetails Other Current and Other Long-term Liabilities (Schedule of Noncurrent Liabilities) (Details) Details http://www.cumberlandpharma.com/role/OtherCurrentandOtherLongtermLiabilitiesTables 62 false false R63.htm 0000063 - Disclosure - Debt (Line of Credit) (Details) Sheet http://www.cumberlandpharma.com/role/DebtLineofCreditDetails Debt (Line of Credit) (Details) Details http://www.cumberlandpharma.com/role/Debt 63 false false R64.htm 0000064 - Disclosure - Shareholders' Equity (Initial Public Offering, Preferred Stock and Common Stock, Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/ShareholdersEquityInitialPublicOfferingPreferredStockandCommonStockNarrativeDetails Shareholders' Equity (Initial Public Offering, Preferred Stock and Common Stock, Narrative) (Details) Details http://www.cumberlandpharma.com/role/ShareholdersEquity 64 false false R65.htm 0000065 - Disclosure - Shareholders' Equity (Share Repurchases, Cumberland Emerging Technologies and Cumberland Foundation Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/ShareholdersEquityShareRepurchasesCumberlandEmergingTechnologiesandCumberlandFoundationNarrativeDetails Shareholders' Equity (Share Repurchases, Cumberland Emerging Technologies and Cumberland Foundation Narrative) (Details) Details http://www.cumberlandpharma.com/role/ShareholdersEquity 65 false false R66.htm 0000066 - Disclosure - Earnings (Loss) Per Share (Schedule of Computation of Numerator and Denominator in Earnings Per Share) (Details) Sheet http://www.cumberlandpharma.com/role/EarningsLossPerShareScheduleofComputationofNumeratorandDenominatorinEarningsPerShareDetails Earnings (Loss) Per Share (Schedule of Computation of Numerator and Denominator in Earnings Per Share) (Details) Details http://www.cumberlandpharma.com/role/EarningsLossPerShareTables 66 false false R67.htm 0000067 - Disclosure - Earnings (Loss) Per Share (Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share) (Details) Sheet http://www.cumberlandpharma.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails Earnings (Loss) Per Share (Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share) (Details) Details http://www.cumberlandpharma.com/role/EarningsLossPerShareTables 67 false false R68.htm 0000068 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities, Net) (Details) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesNetDetails Income Taxes (Schedule of Deferred Tax Assets and Liabilities, Net) (Details) Details http://www.cumberlandpharma.com/role/IncomeTaxesTables 68 false false R69.htm 0000069 - Disclosure - Income Taxes (Schedule of Net Operating Loss Carryforwards) (Details) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesScheduleofNetOperatingLossCarryforwardsDetails Income Taxes (Schedule of Net Operating Loss Carryforwards) (Details) Details http://www.cumberlandpharma.com/role/IncomeTaxesTables 69 false false R70.htm 0000070 - Disclosure - Income Taxes (Schedule of the Components of Income Tax Benefit (Expense) (Details) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesScheduleoftheComponentsofIncomeTaxBenefitExpenseDetails Income Taxes (Schedule of the Components of Income Tax Benefit (Expense) (Details) Details http://www.cumberlandpharma.com/role/IncomeTaxesTables 70 false false R71.htm 0000071 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Details http://www.cumberlandpharma.com/role/IncomeTaxesTables 71 false false R72.htm 0000072 - Disclosure - Income Taxes (Schedule of tax credit carryforwards) (Details) Sheet http://www.cumberlandpharma.com/role/IncomeTaxesScheduleoftaxcreditcarryforwardsDetails Income Taxes (Schedule of tax credit carryforwards) (Details) Details http://www.cumberlandpharma.com/role/IncomeTaxesTables 72 false false R73.htm 0000073 - Disclosure - Stock-Based Compensation Plans (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlansNarrativeDetails Stock-Based Compensation Plans (Narrative) (Details) Details http://www.cumberlandpharma.com/role/StockBasedCompensationPlansTables 73 false false R74.htm 0000074 - Disclosure - Stock-Based Compensation Plans (Schedule of Share-Based Compensation Expense) (Details) Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlansScheduleofShareBasedCompensationExpenseDetails Stock-Based Compensation Plans (Schedule of Share-Based Compensation Expense) (Details) Details http://www.cumberlandpharma.com/role/StockBasedCompensationPlansTables 74 false false R75.htm 0000075 - Disclosure - Stock-Based Compensation Plans (Schedule of Restricted Incentive Stock Activity) (Details) Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlansScheduleofRestrictedIncentiveStockActivityDetails Stock-Based Compensation Plans (Schedule of Restricted Incentive Stock Activity) (Details) Details http://www.cumberlandpharma.com/role/StockBasedCompensationPlansTables 75 false false R76.htm 0000076 - Disclosure - Stock-Based Compensation Plans (Schedule of Restricted Stock Activity) (Details) Sheet http://www.cumberlandpharma.com/role/StockBasedCompensationPlansScheduleofRestrictedStockActivityDetails Stock-Based Compensation Plans (Schedule of Restricted Stock Activity) (Details) Details http://www.cumberlandpharma.com/role/StockBasedCompensationPlansTables 76 false false R77.htm 0000077 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.cumberlandpharma.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://www.cumberlandpharma.com/role/EmployeeBenefitPlans 77 false false R78.htm 0000078 - Disclosure - Leases (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/LeasesNarrativeDetails Leases (Narrative) (Details) Details http://www.cumberlandpharma.com/role/LeasesTables 78 false false R79.htm 0000079 - Disclosure - Leases (Schedule of Rent Expense and Sublease Income) (Details) Sheet http://www.cumberlandpharma.com/role/LeasesScheduleofRentExpenseandSubleaseIncomeDetails Leases (Schedule of Rent Expense and Sublease Income) (Details) Details http://www.cumberlandpharma.com/role/LeasesTables 79 false false R80.htm 0000080 - Disclosure - Leases (Lease Position) (Details) Sheet http://www.cumberlandpharma.com/role/LeasesLeasePositionDetails Leases (Lease Position) (Details) Details http://www.cumberlandpharma.com/role/LeasesTables 80 false false R81.htm 0000081 - Disclosure - Leases (Schedule of Lease Liability Maturities and Future Minimum Payments) (Details) Sheet http://www.cumberlandpharma.com/role/LeasesScheduleofLeaseLiabilityMaturitiesandFutureMinimumPaymentsDetails Leases (Schedule of Lease Liability Maturities and Future Minimum Payments) (Details) Details http://www.cumberlandpharma.com/role/LeasesTables 81 false false R82.htm 0000082 - Disclosure - Market Concentrations (Schedule of Revenues Concentration from Major Customers and Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/MarketConcentrationsScheduleofRevenuesConcentrationfromMajorCustomersandNarrativeDetails Market Concentrations (Schedule of Revenues Concentration from Major Customers and Narrative) (Details) Details http://www.cumberlandpharma.com/role/MarketConcentrationsTables 82 false false R83.htm 0000083 - Disclosure - Manufacturing and Supply Agreements Manufacturing and Supply Agreements (Narrative) (Details) Sheet http://www.cumberlandpharma.com/role/ManufacturingandSupplyAgreementsManufacturingandSupplyAgreementsNarrativeDetails Manufacturing and Supply Agreements Manufacturing and Supply Agreements (Narrative) (Details) Details 83 false false R84.htm 0000084 - Disclosure - Discontinued Operations - Additional Information (Details) Sheet http://www.cumberlandpharma.com/role/DiscontinuedOperationsAdditionalInformationDetails Discontinued Operations - Additional Information (Details) Details 84 false false R85.htm 0000085 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.cumberlandpharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.cumberlandpharma.com/role/CommitmentsandContingencies 85 false false R86.htm 0000086 - Disclosure - Quarterly Financial Information (Schedule of Quarterly Financial Information (Unaudited)) (Details) Sheet http://www.cumberlandpharma.com/role/QuarterlyFinancialInformationScheduleofQuarterlyFinancialInformationUnauditedDetails Quarterly Financial Information (Schedule of Quarterly Financial Information (Unaudited)) (Details) Details http://www.cumberlandpharma.com/role/QuarterlyFinancialInformationUnauditedTables 86 false false R87.htm 0000087 - Disclosure - Valuation and Qualifying Accounts (Details) Sheet http://www.cumberlandpharma.com/role/ValuationandQualifyingAccountsDetails Valuation and Qualifying Accounts (Details) Details 87 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 8 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:DocumentAnnualReport, dei:DocumentPeriodEndDate, dei:DocumentTransitionReport, dei:EntityEmergingGrowthCompany, dei:EntityFilerCategory, dei:EntityShellCompany, dei:EntitySmallBusiness - cpix-20221231.htm 4 [EFM.6.05.45.cover-page-fact-not-visible] Submission type 10-K has 4 cover page fact(s) in ix:hidden that should be visible or referenced by an -sec-ix-hidden style property: EntityCurrentReportingStatus, EntityInteractiveDataCurrent, EntityVoluntaryFilers, EntityWellKnownSeasonedIssuer - cpix-20221231.htm 4 - cpix-20221231.htm 4 cpix-20221231.htm a2022-10kxex1011ajkazimi.htm a2022-10kxex1014johnhamm.htm a2022-10kxex1015jimherman.htm a2022-10kxexhibit311.htm a2022-10kxexhibit312.htm a2022-10kxexhibit321.htm a2022-xex232consentofforvi.htm a2022q4exhibit411.htm cpix-20221231.xsd cpix-20221231_cal.xml cpix-20221231_def.xml cpix-20221231_lab.xml cpix-20221231_pre.xml cpix-20221231_g1.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true